Brief: Humacyte Q2 Operating Expenses USD 27.402 Million
12/08/2026 12:01
BRIEF-Humacyte Q2 Operating Expenses USD 27.402 Million Aug 12 (Reuters) - Humacyte Q2 net income USD -36.802 million vs. IBES estimate USD -22.8 million.
- Q2 basic EPS USD -0.16
- Q2 operating income USD -26.996 million vs. IBES estimate USD -22.1 million
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary